Overview
The Rhesus (Rh) blood group system is the second most clinically important blood group system after ABO, and Rh typing is performed routinely alongside ABO grouping on every donor and recipient sample in the blood bank.
The D antigen is the most immunogenic red cell antigen after the ABO antigens, and its mismanagement can result in severe hemolytic disease of the newborn or transfusion reactions. This lesson covers the antigens and antibodies of the Rh system, the significance of Rh typing, and the laboratory techniques — slide, tube, microplate, and gel — used to determine Rh status.
Learning Objectives
After this lesson you will be able to…- Describe the major antigens of the Rh blood group system
- Explain the nature and clinical significance of Rh antibodies
- Discuss the Du phenotype and its importance in donor and recipient testing
- Compare the slide, tube, microplate, and gel techniques for Rh typing
- Interpret ABO and Rh grouping results including forward and reverse grouping
Clinical Story
Why This MattersA 24-year-old Rh-negative woman is pregnant with her second child. Her first child was Rh-positive and the delivery was uneventful, but her physician is concerned about sensitization from that first pregnancy. The blood bank technologist must correctly determine her Rh status and screen for anti-D antibodies to guide the administration of Rh immunoglobulin and prevent hemolytic disease of the newborn in this pregnancy.
Core Concepts
The most significant Rh antigen is D, owing to its high immunogenicity. Individuals are labeled Rh positive or negative based on the presence or absence of D on the red cell surface. In India, approximately 95% of the population is Rh positive and 5% Rh negative. Four additional antigens — C, c, E, e — are also part of the system. Unlike ABO antigens, Rh antigens occur only on red cells, encoded by two adjacent genes on chromosome 1: RHD (confers D activity; absent in D-negative individuals) and RHCE (determines C, c, E, e expression).
Rh antibodies are always immune in nature (IgG), forming only after exposure to D-positive red cells via transfusion or pregnancy — never naturally occurring as in ABO. Once formed, they persist for years, and re-exposure triggers a rapid secondary response. Rh antibodies are the leading cause of hemolytic disease of the newborn because IgG crosses the placenta and destroys fetal red cells. More than 80% of D-negative individuals transfused with D-positive blood develop anti-D.
Du is a weaker variant of the D antigen; Du red cells agglutinate with some anti-D antisera but not others, and non-agglutinating cases require the antihuman globulin (AHG) technique for detection. Clinically, Du donor units must be labeled Rh positive (since transfusion to an anti-D patient could cause destruction), while Du recipients are treated as Rh negative. A Du-positive neonate born to an Rh-negative, anti-D-immunized mother is at risk of hemolytic disease of the newborn, and such mothers must receive Rh immunoglobulin.
Rh typing tests specifically for the D antigen using slide, tube, microplate, or gel card methods. Available anti-D antisera include polyclonal human anti-D, high-protein antisera (for slide grouping), saline-reactive antisera, and monoclonal antisera (IgM, or IgM/IgG blends — the latter used for Du testing). The tube technique remains the gold-standard method, combining both cell (forward) grouping and serum (reverse) grouping which must always be cross-checked against each other.
Laboratory Principle
Rh grouping is based on antigen-antibody agglutination: red cells bearing the D antigen agglutinate visibly when mixed with anti-D antisera, while D-negative cells remain in a smooth suspension. Centrifugation-based tube and microplate techniques enhance antigen-antibody contact, improving detection of weak reactions compared to the simpler slide method, while the antiglobulin (Coombs) technique is required to detect weakly expressed Du antigen.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Monoclonal Anti-D Antisera | IgM / IgM+IgG blend | Detects D antigen on red cells | 2–8°C, do not freeze |
| High Protein Anti-D Antisera | Macromolecular additive formulation | Rapid slide grouping | 2–8°C |
| Normal Saline | 0.9% NaCl | Washing and cell suspension preparation | Room temperature |
| Polyspecific AHG Serum | Anti-IgG + Anti-C3d | Du testing / antiglobulin technique | 2–8°C |
Step-by-Step Procedure
Confirm donor/patient identity on the vial matches the request form; prepare a 2–5% red cell suspension in normal saline after three washes.
Label a tube 'Anti-D' and add one drop of anti-D antisera.
Add one drop of the 2–5% red cell suspension to the tube and mix gently.
Leave at room temperature for 15–30 minutes, or centrifuge at 1000 rpm for 1 minute after 5–10 minutes of incubation.
Resuspend the cell button and examine for agglutination or hemolysis, grading the reaction from negative (0) to 4+; confirm negative results microscopically.
Flow Diagram
Quality Control
Known Rh-positive and Rh-negative control cells must be tested alongside every batch of anti-D antisera to confirm reactivity before patient or donor samples are tested; an autocontrol using the patient's own serum and cells should show no agglutination.
Blood transfusion centres should participate in national or regional external quality assessment schemes for immunohematology, submitting unknown samples for Rh typing to confirm ongoing accuracy against peer laboratories.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Agglutination with anti-D | D antigen present — Rh positive | Label unit/patient Rh positive; no RhIg required |
| No agglutination with anti-D (saline reactive) | D antigen absent — Rh negative, pending Du testing | Perform Du testing by AHG technique before final labeling |
| Weak/Du positive by AHG only | Weak D variant present | Donor units labeled Rh positive; recipients treated as Rh negative |
Common Errors & How to Avoid Them
Cause: Relying only on the direct slide/tube reaction without AHG follow-up can miss weakly expressed D antigen.
Prevention: Always perform AHG (indirect antiglobulin) testing on apparently D-negative donor units before final labeling.
Cause: The slide technique mixture dries quickly, and drying can cause cell aggregation that mimics true agglutination.
Prevention: Read slide results promptly within the recommended time window and confirm any positive with a tube or gel method.
Cause: An unexpected reaction in the autocontrol may indicate an autoantibody or technical error rather than true Rh status.
Prevention: Investigate any discrepancy before releasing results; repeat testing and consult a reference laboratory if needed.
Laboratory Tips from the Bench
For Du testing, always use a blend of IgM and IgG monoclonal anti-D — IgM alone will not detect the weak D antigen reliably.
In an emergency or blood camp setting, the slide technique is acceptable for a quick preliminary Rh type, but never use it as the final report — confirm with the tube technique.
Remember: 'Du Donor = Positive, Du Recipient = Negative' — this simple rule prevents both under-transfusion errors and unnecessary sensitization.
Important Notes
D-negative individuals lack the RHD gene entirely rather than carrying an alternate allele — this is why D-negative status is essentially a deletion, not a variant, in most cases.
Unlike ABO antibodies, anti-D and other Rh antibodies never occur without prior exposure to the antigen — a crucial distinction when interpreting unexpected antibody screening results.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgeRh-negative primigravida with an uneventful first Rh-positive delivery, now 28 weeks into her second pregnancy. Physician requests Rh typing and antibody screening to guide RhIg prophylaxis.
A negative antibody screen in an Rh-negative pregnant woman indicates she has not yet been sensitized to the D antigen; prophylactic RhIg should still be administered at 28 weeks and postpartum to prevent future sensitization.
- →Antibody screening must always accompany Rh typing in pregnant women to detect existing sensitization.
- →A negative screen does not eliminate future risk — prophylactic RhIg is still required at 28 weeks and after delivery.
- →Du testing is performed on donor units, not routinely on Rh-negative recipients, who are simply given Rh-negative blood.
Frequently Asked Questions
The D antigen has a larger, more complex extracellular protein structure that presents more immunogenic epitopes to the immune system compared to C, c, E, and e, making it far more likely to provoke an antibody response.
In a true life-threatening emergency where Rh-negative blood is unavailable, Rh-positive blood may be given, but this carries a high risk (over 80%) of sensitization and should be avoided in females of childbearing age whenever possible.
The slide technique is rapid and useful for emergencies but cannot reliably detect weak reactions and dries out quickly; the tube technique is more sensitive, allows longer incubation, and permits both cell and serum grouping simultaneously.
Quick Revision
10-Minute ReviewKey Takeaways
- The Rh system is the second most important blood group system in transfusion practice after ABO.
- The D antigen determines Rh positive/negative status and is highly immunogenic.
- Rh antibodies form only after exposure via transfusion or pregnancy and are IgG in nature.
- The Du phenotype requires special AHG testing and has distinct donor versus recipient handling rules.
- Four methods exist for Rh typing: slide, tube, microplate, and gel card, with tube being the gold standard.
- Correct Rh typing prevents hemolytic disease of the newborn and hemolytic transfusion reactions.
Competency Checklist
Track Your MasteryReferences
- National Institute of Open Schooling. Hematology and Blood Bank Technique, Lesson 12: Rhesus Blood Group System.
- Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 11th ed.
- AABB Technical Manual. 20th ed. American Association of Blood Banks.